Organon & Co. (OGN) News Today

Acadian Asset Management LLC raised its position in Organon & Co. (NYSE:OGN - Free Report) by 2,103,633.3% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 63,112 shares of the company's s

Thompson Siegel & Walmsley LLC increased its position in Organon & Co. (NYSE:OGN - Free Report) by 3.4% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 2,125,922 shares of the company's stock after buying an additional 69,843 s

Texas Permanent School Fund Corp cut its stake in shares of Organon & Co. (NYSE:OGN - Free Report) by 14.4% during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 191,315 shares of the company's stock after selling 32,147 shares during th

Private Management Group Inc. lowered its holdings in Organon & Co. (NYSE:OGN - Free Report) by 19.7% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,859,842 shares of the company's stock after selling 455,474 share

JPMorgan Chase & Co. cut Organon & Co. from a "neutral" rating to an "underweight" rating and raised their price target for the company from $18.00 to $20.00 in a report on Friday.

Van ECK Associates Corp increased its position in shares of Organon & Co. (NYSE:OGN - Free Report) by 21.7% during the second quarter, according to its most recent Form 13F filing with the SEC. The firm owned 209,281 shares of the company's stock after buying an additional 37,371 shares during the

Jackson Creek Investment Advisors LLC bought a new stake in Organon & Co. (NYSE:OGN - Free Report) in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm bought 52,106 shares of the company's stock, valued at approximately $1,079,000. Sev

Convergence Investment Partners LLC lifted its holdings in Organon & Co. (NYSE:OGN - Free Report) by 84.5% in the 2nd quarter, according to its most recent 13F filing with the SEC. The firm owned 62,879 shares of the company's stock after purchasing an additional 28,805 shares during the quarter. C

Allspring Global Investments Holdings LLC lifted its position in shares of Organon & Co. (NYSE:OGN - Free Report) by 207.8% during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 246,004

Principal Financial Group Inc. lessened its stake in shares of Organon & Co. (NYSE:OGN - Free Report) by 4.3% in the second quarter, according to its most recent Form 13F filing with the SEC. The fund owned 2,731,640 shares of the company's stock after selling 121,691 shares during the period. Prin

Miller Howard Investments Inc. NY acquired a new position in shares of Organon & Co. (NYSE:OGN - Free Report) during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm acquired 14,073 shares of the company's stock, valued at

Raymond James & Associates lessened its position in Organon & Co. (NYSE:OGN - Free Report) by 10.4% during the second quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 324,479 shares of the company's stock after selling 37,651 shares during the quarter. Ra

Organon & Co. (NYSE:OGN) Hits New 52-Week High at $22.71

Nisa Investment Advisors LLC lifted its position in Organon & Co. (NYSE:OGN - Free Report) by 84.1% during the 2nd quarter, according to its most recent disclosure with the SEC. The fund owned 74,865 shares of the company's stock after purchasing an additional 34,200 shares during the period. Nisa

Wedge Capital Management L L P NC purchased a new stake in Organon & Co. (NYSE:OGN - Free Report) in the 2nd quarter, according to its most recent filing with the SEC. The institutional investor purchased 1,621,877 shares of the company's stock, valued at approximately $33,573,000. Wedge Capital M

Friedenthal Financial acquired a new position in Organon & Co. (NYSE:OGN - Free Report) in the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 37,127 shares of the company's stock, valued at appro

U.S. Capital Wealth Advisors LLC decreased its position in Organon & Co. (NYSE:OGN - Free Report) by 89.6% in the second quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 10,575 shares of the company's stock after selling 91,472 shares during the

Organon & Co. (NYSE:OGN - Get Free Report) released its quarterly earnings results on Tuesday. The company reported $1.12 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.08 by $0.04. Organon & Co. had a net margin of 16.50% and a negative return on equity of 360.57%. The firm had revenue of $1.61 billion for the quarter, compared to the consensus estimate of $1.61 billion. During the same quarter in the previous year, the firm posted $1.31 EPS. The firm's quarterly revenue was down .1% on a year-over-year basis.

Organon & Co. (NYSE:OGN) announced a quarterly dividend on Tuesday, August 6th. Investors of record on Friday, August 16th will be paid a dividend of 0.28 per share on Thursday, September 12th. This represents a $1.12 annualized dividend and a yield of 5.73%. The ex-dividend date of this dividend is Friday, August 16th.

Douglas Lane & Associates LLC grew its stake in Organon & Co. (NYSE:OGN - Free Report) by 8.1% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 527,888 shares of the company's stock after purchasing an additio

Boston Partners acquired a new position in shares of Organon & Co. (NYSE:OGN - Free Report) in the 1st quarter, according to its most recent disclosure with the SEC. The institutional investor acquired 1,028,745 shares of the company's stock, valued at approximately $19,306,000. Boston Partners ow

Tidal Investments LLC boosted its holdings in Organon & Co. (NYSE:OGN - Free Report) by 105.9% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 126,312 shares of the company's stock after ac

Bayesian Capital Management LP purchased a new stake in shares of Organon & Co. (NYSE:OGN - Free Report) in the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 25,173 shares of the company's stock, valued at appro

Organon & Co. (NYSE:OGN) will be releasing earnings before the market opens on Tuesday, August 6, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=417575)

O Shaughnessy Asset Management LLC grew its holdings in Organon & Co. (NYSE:OGN - Free Report) by 187.1% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 39,758 shares of the company's stock after acquiring an additional 25,909

Vanguard Group Inc. increased its position in shares of Organon & Co. (NYSE:OGN - Free Report) by 0.6% during the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 30,789,850 shares of the company's stock after acquiring an addit

UniSuper Management Pty Ltd bought a new position in Organon & Co. (NYSE:OGN - Free Report) during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 52,234 shares of the company's stock, valued at approximately $982,000. A num

Mitsubishi UFJ Trust & Banking Corp lifted its position in Organon & Co. (NYSE:OGN - Free Report) by 20.0% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 427,575 shares of the company's stock after acquiring an additional 71,2

Prevail Innovative Wealth Advisors LLC trimmed its position in Organon & Co. (NYSE:OGN - Free Report) by 68.6% in the first quarter, according to its most recent filing with the SEC. The fund owned 72,656 shares of the company's stock after selling 158,719 shares during the period. Prevail Innovati

Russell Investments Group Ltd. boosted its position in Organon & Co. (NYSE:OGN - Free Report) by 20.5% in the 1st quarter, according to its most recent filing with the SEC. The fund owned 1,634,478 shares of the company's stock after purchasing an additional 278,146 shares during the period. Russel

Susquehanna Fundamental Investments LLC acquired a new position in Organon & Co. (NYSE:OGN - Free Report) in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 334,277 shares of the company's stock, valued at approximately

LSV Asset Management lifted its holdings in Organon & Co. (NYSE:OGN - Free Report) by 34.0% during the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 4,488,828 shares of the company's stock after buying an additional 1,139,249 shares during the